share_log

华康生物医学(08622)完成配售3100万股 净筹约296万港元

Huakang Biomedical (08622) completed placement of 31 million shares to raise approximately HK$2.96 million

Zhitong Finance ·  Apr 23 07:27

Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met, and on April 2, 2024...

Zhitong Finance App News, Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met and completed on April 23, 2024. The placement agent has successfully placed a total of 31 million shares to no less than six undertakers at the placement price of HK$0.097 per share in accordance with the terms and conditions of the placement agreement. The net proceeds from the placement are approximately HK$2.96 million, which is intended to be used as general working capital for the Group's operations outside of China.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment